Observational studyAdvances in therapy2025
Association of Migraine Comorbidities with Quality of Life, Work Productivity and Daily Activities: Survey and Medical Claims Data in Japan.
Observational study in Advances in therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Associations Between Type D Personality, Psychological Symptoms, Pain Severity, and Migraine-Related Outcomes in Women with Migraine.Journal of clinical medicine · 2026Article
- Association of migraine with subsequent risk of depression or anxiety by small-area deprivation: national cohort study with sibling analysis.The journal of headache and pain · 2026Article
- Geographical patterns and determinants of migraine in persons aged ten years or older living in Sweden from 2015 to 2023: a nationwide cross-sectional study.The journal of headache and pain · 2026Article
- Interictal burden, not ictal burden, drives work productivity impairment in headache disorders: insights from a Japanese cross-sectional study.The journal of headache and pain · 2026Article
- Associations of diverse diseases with work productivity among Japanese workers in the context of multimorbidity: additional analysis of a database study.Journal of occupational health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMigraine compromises the quality of life (QOL) and work productivity and daily activities (WPAI). Among those with migraine, comorbidities are relatively common and diverse and are expected to elevate the disease burden. Most previous studies focused on specific psychiatric diseases or conditions and did not encompass common comorbidities. This study aimed to explore the association between various migraine comorbidities, migraine-specific quality of life (MSQ), and WPAI.
methodsThis was a post hoc analysis of an observational study using a pre-existing database of individuals covered by public employment-based health insurance in Japan. This analysis included respondents who participated in a previous study using online survey data (response rate 14.1% [21,704/153,545]) and linked medical claims data, and had migraine and at least 1 year of claims data. The MSQ Questionnaire version 2.1 score was compared, and the odds of having worse WPAI Questionnaire-General Health scores were explored between the subgroups with and without each comorbidity (e.g., depression, sleep disorders, cerebrovascular disorders, and schizophrenia).
resultsOf the 674 respondents, a few had cerebrovascular disorders (n = 6 [0.9%]) or schizophrenia (n = 8 [1.2%]). Except for these comorbidities, the MSQ domain score was significantly lower in participants with depression (n = 43 [6.4%]) (estimated difference [95% confidence interval, CI], role function-restrictive - 6.9 [ - 13.4, - 0.5]; role function-preventive - 7.7 [ - 13.9, - 1.5]) and sleep disorders (n = 55 [8.2%]) (emotional function - 7.2 [ - 13.7, - 0.7]). The odds ratio (95% CI) for having a worse WPAI was significantly higher in those with depression (activity impairment 2.85 [1.13, 7.2]) and sleep disorders (presenteeism 3.01 [1.33, 6.8]; overall work impairment 2.84 [1.24, 6.5]).
conclusionAmong the various common comorbidities, MSQ and WPAI may be worse in patients with depression and sleep disorders comorbid with migraine. In particular, the MSQ RR and RP domain score differences between those with and without comorbid depression exceeded the minimum important difference.
trial registrationUMIN ID, UMIN000050349.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.